ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc.

World Rank (Aug-2026)
6839
Market Cap (Aug-2026)
1.757 Billion USD
Market Cap (Mar-08-2026)
1.663 Billion USD
World Rank (Jan-05-2024)
7,914
Market Cap (Jan-05-2024)
1.149 Billion USD
World Rank (Jul-30-2023)
8,477
Market Cap (Jul-30-2023)
1.055 Billion USD
World Rank (Jan-07-2022)
11,253
Market Cap (Jan-07-2022)
0.731 Billion USD
World Rank (Jan-01-2021)
12,915
Market Cap (Jan-01-2021)
0.352 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Top Pharmaceutical Companies in USA
Nasdaq / NYSE Code
ANIP
Employee Count
601
Employee Count as of Date
As on 2021
Headquarters City/State
Minnesota
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
883 Million USD
Annual Operating Income in USD
111 Million USD
Annual Net Income in USD
78 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
1,440 Million USD
Total Liabilities in USD
900 Million USD
Total Equity in USD
541 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
ANI PHARMACEUTICALS INC
Yahoo
Yahoo @ Stuttgart
Company Profile
ANI Pharmaceuticals is an Integrated Specialty Pharmaceutical company. It is focused on delivering value to customers by developing, manufacturing and marketing high quality branded and generic prescription pharmaceuticals. The company annual revenue is 206.5 million USD and 338 employees as on 2019. The headquarters is in USA.
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share